{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:58:08Z","timestamp":1771873088239,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To evaluate the efficacy of mesenchymal stem cells (MSCs) as an adjuvant therapy for cytomegalovirus (CMV) pneumonia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) through a prospective study.\u00a0From June 2016 to June 2022, 43 patients were diagnosed with CMV pneumonia after allo-HSCT and received antiviral therapy, of whom 24 received MSCs infusion. The primary endpoints of the study were the cure rate and the time to cure of CMV pneumonia, and the secondary endpoint was the overall survival after CMV pneumonia.\u00a0The 2-year overall survival post-pneumonia in MSCs group was significantly better than that in non-MSCs group (74% vs. 50%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.034). Cure rate of pneumonia in MSCs group was higher than that in non-MSCs group without statistical significance (79% vs. 63%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.245). Time (days) to cure in MSCs group was shorter than that in non-MSCs group without statistical significance (39[14\u2013142] vs. 54[6-157],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.765).\u00a0The high mortality rate of CMV pneumonia after allo-HSCT leads to a poor prognosis. The use of MSCs improves the overall survival of CMV pneumonia. The cure rate and time to cure of pneumonia were not improved statistically. At present, there is still a lack of prospective studies on MSCs in the treatment of pneumonia after HSCT, which needs to be supplemented in the future.\n                  <\/jats:p>","DOI":"10.1007\/s00277-025-06684-5","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T07:00:05Z","timestamp":1759906805000},"page":"4811-4820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesenchymal stem cells for the adjunctive treatment of cytomegalovirus pneumonia in hematopoietic stem cell transplant recipients: a Single-center prospective study"],"prefix":"10.1007","volume":"104","author":[{"given":"Xianghui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaihong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianmin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"8","key":"6684_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.bmt.1702877","volume":"27","author":"S Konoplev","year":"2001","unstructured":"Konoplev S, Champlin RE, Giralt S et al (2001) Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 27(8):877\u2013881","journal-title":"Bone Marrow Transplant"},{"key":"6684_CR2","doi-asserted-by":"crossref","unstructured":"Boeckh M, Nichols WG, Papanicolaou G et al (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies.\u00a0Biol Blood Marrow Transplant 9(9):543\u2013558","DOI":"10.1016\/S1083-8791(03)00287-8"},{"issue":"4","key":"6684_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2141.2003.04671.x","volume":"123","author":"C Junghanss","year":"2003","unstructured":"Junghanss C, Storb R, Maris MB et al (2003) Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation [J]. Br J Haematol 123(4):662\u2013670","journal-title":"Br J Haematol"},{"issue":"12","key":"6684_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","volume":"13","author":"JA van Burik","year":"2007","unstructured":"van Burik JA, Carter SL, Freifeld AG et al (2007) Higher risk of cytomegalovirus and Aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease [J]. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation 13(12):1487\u20131498","journal-title":"Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation"},{"issue":"1","key":"6684_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/cid\/civ215","volume":"61","author":"V Erard","year":"2015","unstructured":"Erard V, Guthrie KA, Seo S et al (2015) Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices. Clin Infect Dis 61(1):31\u201339","journal-title":"Clin Infect Dis"},{"key":"6684_CR6","doi-asserted-by":"crossref","unstructured":"Ljungman P, de la Camara R, Robin C et al (2019) Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7) [J]. The Lancet Infectious diseases, 19(8): e260-e72","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"6684_CR7","doi-asserted-by":"crossref","unstructured":"Ishizawa K, Kubo H, Yamada M et al (2004) Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema [J]. FEBS letters, 556(1\u20133): 249\u2009\u2013\u200952","DOI":"10.1016\/S0014-5793(03)01399-1"},{"issue":"1","key":"6684_CR8","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1038\/emm.2016.135","volume":"49","author":"GH Hong","year":"2017","unstructured":"Hong GH, Kwon HS, Lee KY et al (2017) hMSCs suppress neutrophil-dominant airway inflammation in a murine model of asthma [J]. Exp Mol Med 49(1):e288","journal-title":"Exp Mol Med"},{"issue":"5411","key":"6684_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells [J]. Science 284(5411):143\u2013147","journal-title":"Science"},{"key":"6684_CR10","doi-asserted-by":"crossref","unstructured":"Zhou Y, Yamamoto Y, Xiao Z et al (2019) The Immunomodulatory functions of mesenchymal Stromal\/Stem cells mediated via paracrine activity. J Clin Med 8(7):1025","DOI":"10.3390\/jcm8071025"},{"issue":"13","key":"6684_CR11","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1073\/pnas.1601911113","volume":"113","author":"MC Chan","year":"2016","unstructured":"Chan MC, Kuok DI, Leung CY et al (2016) Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. Proc Natl Acad Sci U S A 113(13):3621\u20133626","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6684_CR12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.eng.2020.02.006","volume":"6","author":"J Chen","year":"2020","unstructured":"Chen J, Hu C, Chen L (2020) Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment [J]. Engineering 6(10):1153\u20131161","journal-title":"Engineering"},{"issue":"9","key":"6684_CR13","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/term.2914","volume":"13","author":"C Brown","year":"2019","unstructured":"Brown C, Mckee C, Bakshi S et al (2019) Mesenchymal stem cells: cell therapy and regeneration potential [J]. J Tissue Eng Regen Med 13(9):1738\u20131755","journal-title":"J Tissue Eng Regen Med"},{"issue":"9","key":"6684_CR14","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.4252\/wjsc.v13.i9.1318","volume":"13","author":"E Abu-el-Rub","year":"2021","unstructured":"Abu-el-Rub E, Khasawneh RR, Almahasneh F (2021) Mesenchymal stem cells and COVID-19: what they do and what they can do. World J Stem Cells 13(9):1318\u20131337","journal-title":"World J Stem Cells"},{"issue":"1","key":"6684_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41392-021-00754-6","volume":"6","author":"L Shi","year":"2021","unstructured":"Shi L, Wang L, Xu R et al (2021) Mesenchymal stem cell therapy for severe COVID-19 [J]. Signal Transduct Target Therapy 6(1):339","journal-title":"Signal Transduct Target Therapy"},{"key":"6684_CR16","doi-asserted-by":"crossref","unstructured":"Qu Y, Yang X, Zhang X et al (2022) Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study [J], vol 13. Stem cell research & therapy, p 277. 1","DOI":"10.1186\/s13287-022-02960-7"},{"issue":"1","key":"6684_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH et al (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials [J]. Clin Infect Diseases: Official Publication Infect Dis Soc Am 64(1):87\u201391","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"6","key":"6684_CR18","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1002\/jmv.26649","volume":"93","author":"K Leuzinger","year":"2021","unstructured":"Leuzinger K, Stolz D, Gosert R et al (2021) Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho-alveolar lavage fluids. J Med Virol 93(6):3804\u20133812","journal-title":"J Med Virol"},{"issue":"1","key":"6684_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1164\/rccm.200309-1322SO","volume":"170","author":"RM Kotloff","year":"2004","unstructured":"Kotloff RM, Ahya VN, Crawford SW (2004) Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 170(1):22\u201348","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"6684_CR20","first-page":"209","volume":"10","author":"P Ljungman","year":"1995","unstructured":"Ljungman P (1995) Cytomegalovirus pneumonia: presentation, diagnosis, and treatment [J]. Semin Respir Infect 10(4):209\u2013215","journal-title":"Semin Respir Infect"},{"issue":"2","key":"6684_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2217\/fvl.14.102","volume":"10","author":"PP Romero","year":"2015","unstructured":"Romero PP, Blanco P, Gim\u00e9nez E (2015) An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation [J]. Future Virol 10(2):113\u2013134","journal-title":"Future Virol"},{"issue":"6","key":"6684_CR22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00277-023-05216-3","volume":"102","author":"M Keklik","year":"2023","unstructured":"Keklik M, Deveci B, Celik S (2023) Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation [J]. Ann Hematol 102(6):1537\u20131547","journal-title":"Ann Hematol"},{"issue":"Suppl 1","key":"6684_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-019-0235-4","volume":"7","author":"CH Masterson","year":"2019","unstructured":"Masterson CH, Curley GF, Laffey JG (2019) Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns. Intensive Care Med Exp 7(Suppl 1):41","journal-title":"Intensive Care Med Exp"},{"issue":"10","key":"6684_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1164\/rccm.201701-0170OC","volume":"196","author":"TJ Morrison","year":"2017","unstructured":"Morrison TJ, Jackson MV, Cunningham EK et al (2017) Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer [J]. Am J Respir Crit Care Med 196(10):1275\u20131286","journal-title":"Am J Respir Crit Care Med"},{"key":"6684_CR25","doi-asserted-by":"crossref","unstructured":"Chen F, Chen Z, Wu HT (2024) Mesenchymal stem cell-derived exosomes attenuate murine Cytomegalovirus-infected pneumonia via NF-\u03baB\/NLRP3 signaling pathway. Viruses 16(4):619","DOI":"10.3390\/v16040619"},{"issue":"3","key":"6684_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/jamp.2019.1542","volume":"33","author":"SD Mccarthy","year":"2020","unstructured":"Mccarthy SD, Horgan E, Ali A et al (2020) Nebulized mesenchymal stem cell derived conditioned medium retains antibacterial properties against clinical pathogen isolates [J]. J Aerosol Med Pulm Drug Deliv 33(3):140\u2013152","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"6684_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1182\/blood-2004-11-4557","volume":"106","author":"JY Cahn","year":"2005","unstructured":"Cahn JY, Klein JP, Lee SJ et al (2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Soci\u00e9t\u00e9 Fran\u00e7aise de greffe de Mo\u00eblle et Th\u00e9rapie cellulaire (SFGM-TC), Dana Farber cancer Institute (DFCI), and international bone marrow transplant registry (IBMTR) prospective study [J]. Blood 106(4):1495\u20131500","journal-title":"Blood"},{"issue":"10","key":"6684_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70019","volume":"96","author":"\u00d6 Aydin G\u00fc\u00e7L\u00fc","year":"2024","unstructured":"Aydin G\u00fc\u00e7L\u00fc \u00d6, Demird\u00f6\u011fen E, Kazak E (2024) Prognostic significance of plasma cytomegalovirus (CMV) DNA load in immunocompetent patients with CMV pneumonia: a retrospective cohort study [J]. J Med Virol 96(10):e70019","journal-title":"J Med Virol"},{"issue":"3","key":"6684_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","volume":"112","author":"H Karlsson","year":"2008","unstructured":"Karlsson H, Samarasinghe S, Ball LM et al (2008) Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses [J]. Blood 112(3):532\u2013541","journal-title":"Blood"},{"issue":"6","key":"6684_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.bmt.1702562","volume":"26","author":"SM Barry","year":"2000","unstructured":"Barry SM, Johnson MA, Janossy G (2000) Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant 26(6):591\u2013597","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06684-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:30:15Z","timestamp":1761283815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06684-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6684"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06684-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Shanghai General Hospital (approval reference number: 02.DY11.06.22.06, approval date: 2017.01). Title of the approved project is \u201cAntiviral drugs combined with mesenchymal stem cells for the treatment of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation\u201d. Written informed consent was obtained for all patients before they were enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}